Sign in

CIK 0001503802

  • Non-accelerated filer
  • Smaller reporting company

Karyopharm Therapeutics Inc.

Sign in to watch
Tickers
KPTI KPTIQ
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
263931704
Phone
+1 617-658-0600
Business address
85 WELLS AVENUE, SECOND FLOOR, NEWTON, MA, 02459

Securities

  • KPTI Common stock Nasdaq
  • KPTIQ Common stock OTC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$2,135
in 3 filings

Net −$2,135. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Abate Kristin −$2K Chief Accounting Officer sold 22% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-02-15 Frenkel Ran EVP, Chief Dev. Officer Exercise or conversion +9,675 49,013
2021-02-15 Frenkel Ran EVP, Chief Dev. Officer Exercise or conversion · Restricted Stock Units −9,675 19,350
2021-02-15 Shacham Sharon President & CSO Exercise or conversion +21,800 785,947
2021-02-15 Shacham Sharon President & CSO Exercise or conversion +21,800 584,621
2021-02-15 Shacham Sharon President & CSO Exercise or conversion · Restricted Stock Units −21,800 43,600
2021-02-15 Shacham Sharon President & CSO Exercise or conversion · Restricted Stock Units −21,800 43,600
2021-02-15 Kauffman Michael Chief Executive Officer Exercise or conversion +21,800 584,621
2021-02-15 Kauffman Michael Chief Executive Officer Exercise or conversion +21,800 785,947
2021-02-15 Kauffman Michael Chief Executive Officer Exercise or conversion · Restricted Stock Units −21,800 43,600
2021-02-15 Kauffman Michael Chief Executive Officer Exercise or conversion · Restricted Stock Units −21,800 43,600
2021-02-11 Lewis Tanya EVP, Chief Reg. Affairs Sale −2,046 $15.52 $32K 4,143
2021-02-11 Shah Jatin EVP, Chief Medical Officer Sale −1,748 $15.52 $27K 48,127
2021-02-11 Frenkel Ran EVP, Chief Dev. Officer Sale −2,046 $15.52 $32K 39,338
2021-02-11 Mason Michael SVP, CFO & Treasurer Sale −2,858 $15.52 $44K 5,292
2021-02-11 Shacham Sharon President & CSO Sale −6,642 $15.52 $103K 764,147
2021-02-11 Shacham Sharon President & CSO Sale −6,601 $15.52 $102K 562,821
2021-02-11 Kauffman Michael Chief Executive Officer Sale −6,601 $15.52 $102K 562,821
2021-02-11 Kauffman Michael Chief Executive Officer Sale −6,642 $15.52 $103K 764,147
2021-02-05 Shah Jatin EVP, Chief Medical Officer Exercise or conversion +5,650 49,875
2021-02-05 Shah Jatin EVP, Chief Medical Officer Exercise or conversion · Restricted Stock Units −5,650 16,950

Page 18 of 29 · 570 trades